Acute Viral Hepatitis Panel Testing
Viral hepatitis remains a major global public health challenge. The ultimate goal of acute viral hepatitis testing is to detect and confirm evidence of Hepatitis A (HAV), Hepatitis B (HBV), and Hepatitis C (HCV) infections in the blood—the three most common types of viral hepatitis in clinical settings. Through a single, comprehensive serological blood test, the acute viral hepatitis panel efficiently identifies early or recent HAV and HBV infections, and traces whether a patient has been exposed to HCV at some point in the past.
Crucially, this panel detects not only acute (short-term) HAV and HBV infections but also evaluates chronic HBV status. Although chronic hepatitis B is less common than acute hepatitis, it is highly insidious. The virus can persist in the body for years, slowly damaging the liver. Over time, chronic hepatitis can lead to life-threatening complications such as severe liver scarring (cirrhosis), liver failure, and liver cancer. Early screening and definitive diagnosis are key to halting disease progression.
Our Services
The core principle of the acute viral hepatitis panel relies on immunological capture technologies, utilizing multiple independent assays to comprehensively screen the blood for antigens (foreign substances like the virus's own proteins) and antibodies (defensive substances produced by the human immune system in response to viral infection).
Our comprehensive testing panel includes the following core components:
(1) Hepatitis A (HAV) Testing:
- Target: IgM antibody to hepatitis A virus (IgM anti-HAV)
- Clinical Significance: IgM antibodies are early markers of acute infection with exceptional specificity, primarily used to quickly confirm a recent acute HAV infection.
(2) Hepatitis B (HBV) Testing:
- Targets: Hepatitis B surface antigen (HBsAg) and IgM antibody to hepatitis B core antigen (IgM anti-HBc)
- Clinical Significance: The presence of HBsAg indicates the hepatitis B virus is in the body, while IgM anti-HBc is a hallmark of acute infection. Combining these two effectively differentiates between an acute/short-term HBV infection and a long-term chronic HBV infection, providing direct evidence for clinical staging.
(3) Hepatitis C (HCV) Testing:
- Target: Hepatitis C virus antibody (Anti-HCV)
- Clinical Significance: Used to screen for a patient's past or current exposure to the hepatitis C virus.
- Reflex Testing: In certain cases, if the initial antibody screen is positive, we will proceed with a Hepatitis C RNA test. This is a quantitative nucleic acid test specifically designed to measure the amount of HCV genetic material (viral load) in the blood, thereby accurately confirming an active infection and assessing the efficacy of antiviral treatments.
Our Advantages
Our core advantage lies in providing a highly sensitive and specific "one-stop" joint screening solution. A single blood draw covers the three core hepatitis viruses (HAV, HBV, and HCV), which not only significantly boosts diagnostic efficiency but also accurately differentiates between acute and chronic infection stages through a scientifically designed target combination. Furthermore, our platform supports seamless reflex testing; positive HCV antibody samples can automatically trigger an RNA nucleic acid assay to rapidly confirm active infections. This effectively shortens the diagnostic turnaround time, providing solid, reliable data to support early clinical intervention and treatment.
Workflow
We align with your research or clinical diagnostic needs to determine the specific panel combinations and reflex trigger conditions.
Whole blood or serum samples are collected according to strict protocols and delivered to our central laboratory via specialized cold-chain logistics to ensure biomarker stability.
Once samples pass quality inspection, they enter our automated pipeline for simultaneous enzyme-linked or chemiluminescence immunoassay analysis of antigens and antibodies.
We deliver clear positive/negative determinations and provide professional medical testing reports for complex serological patterns (such as HBV multi-marker combinations).
Early screening and accurate diagnosis are the critical first steps in overcoming viral hepatitis and saving patient lives. We are dedicated to providing you with the highest standard and most reliable hepatitis testing services. Whether you are conducting clinical diagnostic support or epidemiological research, we are your trusted testing partner. Contact our expert team today to learn more about our testing details or to customize your exclusive screening plan, and let's use rigorous data to safeguard liver health together!
